Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients

por Heestand, Gregory M., Schwaederle, Maria, Gatalica, Zoran, Arguello, David, Kurzrock, Razelle
Publicado 2017

Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix

por Cimic, Adela, Vranic, Semir, Arguello, David, Contreras, Elma, Gatalica, Zoran, Swensen, Jeffrey
Publicado 2021

HER2 expression status in diverse cancers: review of results from 37,992 patients

por Yan, Min, Schwaederle, Maria, Arguello, David, Millis, Sherri Z., Gatalica, Zoran, Kurzrock, Razelle
Publicado 2015

Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD‐L1 expression in cancer patients

por Nikanjam, Mina, Arguello, David, Gatalica, Zoran, Swensen, Jeff, Barkauskas, Donald A., Kurzrock, Razelle
Publicado 2019

PD-L1 Status in Refractory Lymphomas

por Vranic, Semir, Ghosh, Nilanjan, Kimbrough, Jeffery, Bilalovic, Nurija, Bender, Ryan, Arguello, David, Veloso, Yvonne, Dizdarevic, Aida, Gatalica, Zoran
Publicado 2016

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas

por Smaglo, Brandon G., Tesfaye, Anteneh, Halfdanarson, Thorvardur R., Meyer, Joshua E., Wang, Jue, Gatalica, Zoran, Reddy, Sandeep, Arguello, David, Boland, Patrick M.
Publicado 2015

Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial

por Pierobon, Mariaelena, Robert, Nicholas J., Northfelt, Donald W., Jahanzeb, Mohammad, Wong, Shukmei, Hodge, Kimberly A., Baldelli, Elisa, Aldrich, Jessica, Craig, David W., Liotta, Lance A., Avramovic, Sanja, Wojtusiak, Janusz, Alemi, Farrokh, Wulfkuhle, Julia D., Bellos, Angela, Gallagher, Rosa I., Arguello, David, Conrad, Amber, Kemkes, Ariane, Loesch, David M., Vocila, Linda, Dunetz, Bryant, Carpten, John D., Petricoin, Emanuel F., Anthony, Stephen P.
Publicado 2021